American Kids Aren’t Such Stoners After All
Turns out the young people of America are not as high as you thought they were. The use of illicit drugs, alcohol and tobacco among young people has been falling, according to new data.
While the nationwide rate of illicit drug use has gone up, the percentage of youths using illicit drugs has declined, according to a report from the Substance Abuse and Mental Health Service Administration (SAMSHA), part of the Department of Health and Human Services. The illicit drugs include marijuana/hashish, cocaine (including crack), hallucinogens, heroin, inhalants or prescription-type psychotherapeutics.
Among youths aged 12 to 17, the rate of illicit drug use was down to 8.8 percent in 2013 from 9.5 to 11.6 percent in the years 2002 to 2007, the SAMSHA study said.
Related: New Lifetime Estimate of Obesity Costs: $92,235 Per Person
But in 2013, drug use among those 12 or older was up to 9.4 percent from the 7.9 to 8.7 percent found between 2002 and 2009. The rise was attributed to increased rates of marijuana use, both medical and nonmedical, among adults aged 26 and older — and that rise probably doesn't fully reflect the recent legalization of recreational marijuana in Colorado, Washington, Oregon and Alaska.
The report also suggested that alcohol is losing some of its allure for the young.
Between 2002 and 2013, the percentage of underage people who drank declined from 28.8 percent to 22.7 percent. In addition, the proportion of binge drinkers — those who consumed five or more drinks during one occasion — decreased from 19.3 percent to 14.2 percent in the same years.
In additional good news, tobacco and cigarette use among all age groups has declined sharply since 2002.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
